CPRX
Catalyst Pharmaceuticals Inc
NASDAQ: CPRX · HEALTHCARE · BIOTECHNOLOGY
$31.15
-0.05% today
Updated 2026-05-08
Market cap
$3.81B
P/E ratio
18.55
P/S ratio
6.47x
EPS (TTM)
$1.68
Dividend yield
—
52W range
$19 – $33
Volume
1.9M
WallStSmart proprietary scores
57
out of 100
Grade: C+
Hold
Investment rating
6.0
Growth
B8.5
Quality
A10.0
Profitability
A+5.3
Valuation
C+2/9
Piotroski F-Score
Weak
6.5
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$34.14
+9.60%
12-Month target
$21.59
-30.69%
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 6.50 — safe zone
+ Profit margin 36.40% — above average
+ ROE 25.50% — strong efficiency
+ Free cash flow $44.86M — positive
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 2/9 — weak financial health
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $214.20M | $398.20M | $491.73M | $588.99M | $588.99M |
| Net income | $83.08M | $71.41M | $163.89M | $214.33M | $52.70M |
| EPS | — | — | — | — | $1.68 |
| Free cash flow | $116.02M | $61.86M | $239.25M | $208.61M | $44.86M |
| Profit margin | 38.79% | 17.93% | 33.33% | 36.39% | 36.40% |
Peer comparison
Smart narrative
Catalyst Pharmaceuticals Inc trades at $31.15. representing a P/E of 18.55x trailing earnings. Our Smart Value Score of 57/100 indicates the stock is fair. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 6.50, it sits in the safe zone. TTM revenue stands at $588.99M. with profit margins at 36.40%.
Frequently asked questions
What is Catalyst Pharmaceuticals Inc's stock price?
Catalyst Pharmaceuticals Inc (CPRX) trades at $31.15.
Is Catalyst Pharmaceuticals Inc overvalued?
Smart Value Score 57/100 (Grade C+, Hold).
What is the price target of Catalyst Pharmaceuticals Inc (CPRX)?
The analyst target price is $34.14, representing +9.6% upside from the current price of $31.15.
What is Catalyst Pharmaceuticals Inc's revenue?
TTM revenue is $588.99M.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
6.50 — safe zone.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio6.47x
ROE25.50%
Beta0.72
50D MA$25.47
200D MA$22.89
Shares out0.12B
Float0.11B
Short ratio—
Avg volume1.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—